Explore more at Google Scholar or PubMed

2016

Yao Z, Mates JM, Cheplowitz AM, Hammer LP, Maiseyeu A, Phillips GS, Wewers MD, Rajaram MVS, Robinson JM, Anderson CL, Ganesan LP. Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein. J Immunol 2016 

Maiseyeu A. Non-antigenic regulators of targeting for imaging and therapy. Adv Drug Deliv Rev. 2016;99:1. 

Bagalkot V, Deiuliis JA, Rajagopalan S, Maiseyeu A. “Eat me” imaging and therapy. Adv Drug Deliv Rev. 2016;99:2–11. 

Ganesan LP, Mates JM, Cheplowitz AM, Avila CL, Zimmerer JM, Yao Z, Maiseyeu A, Rajaram MVS, Robinson JM, Anderson CL. Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells. Sci Rep. 2016;6:20646. 

2015

Bagalkot V, Badgeley MA, Kampfrath T, Deiuliis JA, Rajagopalan S, Maiseyeu A. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. J Control Release. 2015;217:243–255. 

Zhong J, Maiseyeu A, Davis SN, Rajagopalan S. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. Circ Res. 2015;116:1491–1504. 

Zhong J, Maiseyeu A, Rajagopalan S. Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors. Clin Lipidol. 2015;10:103–112. 

2014

Liu C, Fonken LK, Wang A, Maiseyeu A, Bai Y, Wang T-Y, Maurya S, Ko Y-A, Periasamy M, Dvonch T, Morishita M, Brook RD, Harkema J, Ying Z, Mukherjee B, Sun Q, Nelson RJ, Rajagopalan S. Central IKKβ inhibition prevents air pollution mediated peripheral inflammation and exaggeration of type II diabetes. Part Fibre Toxicol. 2014;11:53. 

Rao X, Zhong J, Maiseyeu A, Gopalakrishnan B, Villamena FA, Chen L-C, Harkema JR, Sun Q, Rajagopalan S. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circ Res. 2014;115:770–780. 

Maiseyeu A, Bagalkot V. In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line. Nanoscale Res Lett. 2014;9:176. 

Deiuliis J, Mihai G, Zhang J, Taslim C, Varghese JJ, Maiseyeu A, Huang K, Rajagopalan S. Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J Hum Hypertens. 2014;28:251–258.

Maiseyeu A, Yang H-Y, Ramanathan G, Yin F, Bard RL, Morishita M, Dvonch JT, Wang L, Spino C, Mukherjee B, Badgeley MA, Barajas-Espinosa A, Sun Q, Harkema J, Rajagopalan S, Araujo JA, Brook RD. No effect of acute exposure to coarse particulate matter air pollution in a rural location on high-density lipoprotein function. Inhal Toxicol. 2014;26:23–29. 

Liu C, Xu X, Bai Y, Wang T-Y, Rao X, Wang A, Sun L, Ying Z, Gushchina L, Maiseyeu A, Morishita M, Sun Q, Harkema JR, Rajagopalan S. Air pollution-mediated susceptibility to inflammation and insulin resistance: influence of CCR2 pathways in mice. Environ Health Perspect. 2014;122:17–26. 

Giri S, Xue H, Maiseyeu A, Kroeker R, Rajagopalan S, White RD, Zuehlsdorff S, Raman SV, Simonetti OP. Steady-state first-pass perfusion (SSFPP): a new approach to 3D first-pass myocardial perfusion imaging. Magn Reson Med. 2014;71:133–144. 

2013

Rajagopalan S, Badgeley MA, Maiseyeu A. Cholesterol Efflux Assay Probe Formulations, Methods of Making and Using. US Patent. 2013

Blazek A, Rutsky J, Osei K, Maiseyeu A, Rajagopalan S. Exercise-mediated changes in high-density lipoprotein: impact on form and function. Am Heart J. 2013;166:392–400. 

Sun L, Liu C, Xu X, Ying Z, Maiseyeu A, Wang A, Allen K, Lewandowski RP, Bramble LA, Morishita M, Wagner JG, Dvonch J, Sun Z, Yan X, Brook RD, Rajagopalan S, Harkema JR, Sun Q, Fan Z. Ambient fine particulate matter and ozone exposures induce inflammation in epicardial and perirenal adipose tissues in rats fed a high fructose diet. Part Fibre Toxicol. 2013;10:43. 

Mihai G, Varghese J, Kampfrath T, Gushchina L, Hafer L, Deiuliis J, Maiseyeu A, Simonetti OP, Lu B, Rajagopalan S. Aliskiren Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double-Blind Placebo-Controlled Trial. J Am Heart Assoc. 2013;2.

Sharkey-Toppen TP, Mihai G, Maiseyeu A, Tran T, Clymer BD, Simonetti OP, Raman SV. Improved in vivo human carotid artery wall T₂ estimation. Magn Reson Imaging. 2013;31:44–52. 

2012

Liu C, Desikan R, Ying Z, Gushchina L, Kampfrath T, Deiuliis J, Wang A, Xu X, Zhong J, Rao X, Sun Q, Maiseyeu A, Parthasarathy S, Rajagopalan S. Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model. PLoS One. 2012;7:e50767. 

Xu X, Rao X, Wang T-Y, Jiang SY, Ying Z, Liu C, Wang A, Zhong M, Deiuliis JA, Maiseyeu A, Rajagopalan S, Lippmann M, Chen L-C, Sun Q. Effect of co-exposure to nickel and particulate matter on insulin resistance and mitochondrial dysfunction in a mouse model. Part Fibre Toxicol. 2012;9:40. 

Yang F, Zhang X, Maiseyeu A, Mihai G, Yasmeen R, DiSilvestro D, Maurya SK, Periasamy M, Bergdall KV, Duester G, Sen CK, Roy S, Lee LJ, Rajagopalan S, Ziouzenkova O. The prolonged survival of fibroblasts with forced lipid catabolism in visceral fat following encapsulation in alginate-poly-L-lysine. Biomaterials. 2012;33:5638–5649. 

Ying Z, Desikan R, Xu X, Maiseyeu A, Liu C, Sun Q, Ziouzenkova O, Parthasarathy S, Rajagopalan S. Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression. J Lipid Res. 2012;53:879–887. 

Maiseyeu A, Badgeley MA, Kampfrath T, Mihai G, Deiuliis JA, Liu C, Sun Q, Parthasarathy S, Simon DI, Croce K, Rajagopalan S. In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles. Arterioscler Thromb Vasc Biol. 2012;32:962–970. 

Deiuliis JA, Kampfrath T, Zhong J, Oghumu S, Maiseyeu A, Chen LC, Sun Q, Satoskar AR, Rajagopalan S. Pulmonary T cell activation in response to chronic particulate air pollution. Am J Physiol Lung Cell Mol Physiol. 2012;302:L399–409. 

Xu X, Rao X, Wang T-Y, Jiang SY, Ying Z, Liu C, Wang A, Zhong M, Deiuliis JA, Maiseyeu A. Effect of co-exposure to nickel and particulate matter on insulin resistance and mitochondrial dysfunction in a mouse model. Part Fibre Toxicol. 2012;9:40.

Bandyopadhyay S, Xia X, Maiseiyeu A, Mihai G, Rajagopalan S, Bong D. Z-Group Ketone Chain Transfer Agents for RAFT Polymer Nanoparticle Modification via Hydrazone Conjugation. Macromolecules. 2012; 11;45(17):6766-6773.

Before 2012

Krasovsky AL, Moiseev AM, Nenajdenko VG, Balenkova ES. Cyclocondensation of 2-Amino-1, 3, 4-thiadiazoles with β-Sulfonylvinyltrifluoromethyldiols. Chem Heterocycl Compd . 2002;38:231–237.

Krasovsky AL, Moiseev AM, Nenajdenko VG, Balenkova ES. Synthesis of New Fluorine Containing Triazolo-and Tetrazolopyrimidines. Synthesis . 2002;2002:901–905.

Krasovsky AL, Moiseev AM, Nenajdenko VG, Balenkova ES. Reaction of 2-Aminothiazoles and Their Benzo-and Naphtho Derivatives with β-Sulfonyltrifluoromethylvinyldiols. Chem Heterocycl Compd . 2004;40:667–675.

Nenajdenko VG, Moiseev AM, Balenkova ES. A novel method for the oxidation of thiophenes. Synthesis of thiophene 1, 1-dioxides containing electron-withdrawing substituents. Russ Chem Bull. 2004;53:2241–2247.

Nenajdenko VG, Moiseev AM, Balenkova ES. Chemo-, regio-and stereoselective Diels-Alder reactions of EWG bearing thiophene-1, 1-dioxides. Tetrahedron. 2005;61:10880–10885.

Nenajdenko VG, Moiseev AM, Balenkova ES. Reactions of acceptor thiophene 1, 1-dioxides with dienes. Synthesis of bisadducts. Russ Chem Bull. 2005;54:2182–2186.

Moiseev AM, Balenkova ES, Nenajdenko VG. Reactions of electron-withdrawing thiophene 1, 1-dioxides with furans. A novel reaction pathway. Russ Chem Bull. 2006;55:712–717.

Moiseev AM, Balenkova ES, Nenajdenko VG. Thiophene 1, 1-dioxides as unique building blocks in modern organic synthesis and materials chemistry. Russ Chem Rev. 2006;75:1015.

Moiseev AM, Tyurin DD, Balenkova ES, Nenajdenko VG. Reactions of acceptor substituted thiophene-1, 1-dioxides with cyclopentadiene: control of selectivity by substitution. Tetrahedron. 2006;62:4139–4145.

Moiseev AM, Balenkova ES, Nenajdenko VG. [6+ 4] Cycloaddition reactions of acceptor thiophene dioxides: The synthesis of substituted azulenes. Russ Chem Bull. 2006;55:141–146.

Moiseev AM, Balenkova ES, Nenajdenko VG. EWG-containing thiophene- and 2-thiolene-1,1-dioxides as promising electrophiles for organic synthesis. Mendeleev Commun. 2006;16:215–218. 

Maiseyeu A, Mihai G, Kampfrath T, Simonetti OP, Sen CK, Roy S, Rajagopalan S, Parthasarathy S. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis. J Lipid Res. 2009;50:2157–2163. 

Maiseyeu A, Mihai G, Roy S, Kherada N, Simonetti OP, Sen CK, Sun Q, Parthasarathy S, Rajagopalan S. Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging. Nanomedicine. 2010;5:1341–1356. 

Deiuliis JA, Kampfrath T, Ying Z, Maiseyeu A, Rajagopalan S. Lipoic acid attenuates innate immune infiltration and activation in the visceral adipose tissue of obese insulin resistant mice. Lipids. 2011;46:1021–1032.

Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q, Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res. 2011;108:716–726. 

Reichert B, Yasmeen R, Jeyakumar SM, Yang F, Thomou T, Alder H, Duester G, Maiseyeu A, Mihai G, Harrison EH, Rajagopalan S, Kirkland JL, Ziouzenkova O. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol Endocrinol. 2011;25:799–809. 

Shah Z, Pineda C, Kampfrath T, Maiseyeu A, Ying Z, Racoma I, Deiuliis J, Xu X, Sun Q, Moffatt-Bruce S, Villamena F, Rajagopalan S. Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways. Vascul Pharmacol. 2011;55:2–9. 

Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, Xu X, Lu B, Moffatt-Bruce S, Durairaj R, Sun Q, Mihai G, Maiseyeu A, Rajagopalan S. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation. 2011;124:2338–2349.